EP3363456
Nýstárleg ónæmismeðferð við allmörgum æxlum að meðtöldu krabbameini í ristli og endaþarmi og magakrabbameini
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.3.2011EP published:
5.8.2020EP application number:
18156634.0
EP translation filed:
2.11.2020Grant published:
15.12.2020EPO information:
European Patent Register
Max expiry date:
14.3.2031Expiry date:
14.3.2024
Title:
NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER
Timeline
Today
15.3.2011EP application
5.8.2020EP Publication
2.11.2020Translation submitted
15.12.2020Registration published
14.3.2024Expires
Owner
Name:
immatics Biotechnologies GmbHAddress:
Paul-Ehrlich-Straße 15, 72076 Tübingen, DE
Inventor
Name:
Weinschenk, ToniAddress:
73773 Aichwald, DE
Name:
Fritsche, JensAddress:
72144 Dusslingen, DE
Name:
Walter, SteffenAddress:
Houston, TX Texas 77005, US
Name:
Lewandrowski, PeterAddress:
72070 Tübingen-Hirschau, DE
Name:
Singh, HarpreetAddress:
Houston, TX Texas 77005, US
Agent
Name:
KIPA ABAddress:
Pósthólf 1065, Drottninggatan 11, SE
Priority
Number:
315704 PDate:
19.3.2010Country:
US
Number:
201004551Date:
19.3.2010Country:
GB
Classification
Categories:
A61K 38/17, A61K 39/00, C07K 7/06, C07K 7/08, G01N 33/50, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 18.3.2021
Expires: 14.3.2022
Payer: Patice ehf.
Number: 12
Paid: 17.3.2022
Expires: 14.3.2023
Payer: Patice ehf.
Number: 13
Paid: 17.3.2023
Expires: 14.3.2024
Payer: Árnason Faktor ehf.